G1 Therapeutics
(NASDAQ:GTHX)
$4.41
-0.06[-1.34%]
At close: Mar 28
$4.41
0[0.00%]
After Hours: 7:59PM EDT
Consensus Rating1
Buy
Highest Price Target1
$56.00
Lowest Price Target1
$4.00
Consensus Price Target1
$15.71

G1 Therapeutics Stock (NASDAQ:GTHX), Analyst Ratings, Price Targets, Predictions

G1 Therapeutics Inc has a consensus price target of $15.71, established from looking at the 33 latest analyst ratings. The last 3 analyst ratings were released from Needham, Wedbush, and Needham on February 28, 2024, February 13, 2024, and February 13, 2024. With an average price target of $9.33 between Needham, Wedbush, and Needham, there's an implied 111.64% upside for G1 Therapeutics Inc from these 3 analyst ratings.

Analyst Rating Summary1

Analyst Ratings
Oct 23
1
1
Dec 23
1
Jan
1
Feb
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Needham
Wedbush
JP Morgan
HC Wainwright & Co.
EF Hutton

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for G1 Therapeutics

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/28/2024GTHXBuy Now
G1 Therapeutics
$4.41172.11%Needham
Gil Blum
→ $12ReiteratesBuy → BuyGet Alert
02/13/2024GTHXBuy Now
G1 Therapeutics
$4.41-9.3%Wedbush
David Nierengarten
$5 → $4MaintainsOutperformGet Alert
02/13/2024GTHXBuy Now
G1 Therapeutics
$4.41172.11%Needham
Gil Blum
$14 → $12MaintainsBuyGet Alert
01/24/2024GTHXBuy Now
G1 Therapeutics
$4.41217.46%Needham
Gil Blum
→ $14ReiteratesBuy → BuyGet Alert
12/06/2023GTHXBuy Now
G1 Therapeutics
$4.41217.46%Needham
Gil Blum
→ $14ReiteratesBuy → BuyGet Alert
10/30/2023GTHXBuy Now
G1 Therapeutics
$4.4113.38%Wedbush
David Nierengarten
→ $5ReiteratesOutperform → OutperformGet Alert
10/06/2023GTHXBuy Now
G1 Therapeutics
$4.41JP Morgan
Anupam Rama
DowngradeNeutral → UnderweightGet Alert
08/03/2023GTHXBuy Now
G1 Therapeutics
$4.4113.38%Wedbush
David Nierengarten
→ $5ReiteratesOutperform → OutperformGet Alert
08/03/2023GTHXBuy Now
G1 Therapeutics
$4.41149.43%HC Wainwright & Co.
Edward White
→ $11ReiteratesBuy → BuyGet Alert
08/02/2023GTHXBuy Now
G1 Therapeutics
$4.41330.84%EF Hutton
Tony Butler
→ $19Reiterates → BuyGet Alert
08/02/2023GTHXBuy Now
G1 Therapeutics
$4.41217.46%Needham
Gil Blum
$18 → $14MaintainsBuyGet Alert
06/26/2023GTHXBuy Now
G1 Therapeutics
$4.41149.43%HC Wainwright & Co.
Edward White
→ $11ReiteratesBuy → BuyGet Alert
06/05/2023GTHXBuy Now
G1 Therapeutics
$4.41149.43%HC Wainwright & Co.
Edward White
→ $11ReiteratesBuy → BuyGet Alert
06/05/2023GTHXBuy Now
G1 Therapeutics
$4.41308.16%Needham
Gil Blum
→ $18ReiteratesBuy → BuyGet Alert
05/04/2023GTHXBuy Now
G1 Therapeutics
$4.41149.43%HC Wainwright & Co.
Edward White
→ $11Reiterates → BuyGet Alert
05/04/2023GTHXBuy Now
G1 Therapeutics
$4.4181.41%Raymond James
Dane Leone
$24 → $8MaintainsOutperformGet Alert
04/19/2023GTHXBuy Now
G1 Therapeutics
$4.41308.16%Needham
Gil Blum
→ $18Reiterates → BuyGet Alert
03/02/2023GTHXBuy Now
G1 Therapeutics
$4.41149.43%HC Wainwright & Co.
Edward White
→ $11Reiterates → BuyGet Alert
02/14/2023GTHXBuy Now
G1 Therapeutics
$4.41308.16%Needham
Gil Blum
$31 → $18MaintainsBuyGet Alert

FAQ

Q

What is the target price for G1 Therapeutics (GTHX)?

A

The latest price target for G1 Therapeutics (NASDAQ: GTHX) was reported by Needham on February 28, 2024. The analyst firm set a price target for $12.00 expecting GTHX to rise to within 12 months (a possible 172.11% upside). 17 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for G1 Therapeutics (GTHX)?

A

The latest analyst rating for G1 Therapeutics (NASDAQ: GTHX) was provided by Needham, and G1 Therapeutics reiterated their buy rating.

Q

When was the last upgrade for G1 Therapeutics (GTHX)?

A

The last upgrade for G1 Therapeutics Inc happened on January 30, 2023 when JP Morgan raised their price target to $10. JP Morgan previously had an underweight for G1 Therapeutics Inc.

Q

When was the last downgrade for G1 Therapeutics (GTHX)?

A

The last downgrade for G1 Therapeutics Inc happened on October 6, 2023 when JP Morgan changed their price target from N/A to N/A for G1 Therapeutics Inc.

Q

When is the next analyst rating going to be posted or updated for G1 Therapeutics (GTHX)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of G1 Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for G1 Therapeutics was filed on February 28, 2024 so you should expect the next rating to be made available sometime around February 28, 2025.

Q

Is the Analyst Rating G1 Therapeutics (GTHX) correct?

A

While ratings are subjective and will change, the latest G1 Therapeutics (GTHX) rating was a reiterated with a price target of $0.00 to $12.00. The current price G1 Therapeutics (GTHX) is trading at is $4.41, which is within the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch